Cohort Studymoderate evidence
A prospective multidimensional assessment of the impact of payer type, insurance delays, psychological and clinical domains on response to 60-day peripheral nerve stimulation: 6-month outcomes.
Pain medicine (Malden, Mass.)·May 1, 2026·PMID 41148054
Why it mattersInsurance delays are a modifiable barrier that dramatically reduce PNS effectiveness—each 10-day delay cut odds of ≥50% relief by 89%. Recognizing that many patients respond late (after lead removal) can prevent premature therapy abandonment and guide realistic patient counseling.
The papers that matter, first.
MedLit ranks the medical literature into a specialty feed with concise summaries, evidence-aware triage, and visual takeaways.
§
MedLit · Evidence, Distilled